Penumbra Launches Next Gen DTx VR system, for Clinical Rehab

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today introduced the REAL Immersive System y-Series, expanding its comprehensive virtual reality-based healthcare platform with significantly more activities and experiences now available to help improve patient care, including clinical rehabilitation therapy. With TherapyView™, an enhanced therapist interface, clinicians can customize therapy programs based on individual needs to challenge, motivate and engage patients.

REAL y-Series includes upgraded hardware and sensor technology to address needs spanning a wider range of rehab patients. The expanded content library includes activities that address motor skills, cognition, core and balance, functional tasks, activities of daily living (ADLs), vision and wellness. Many of these activities can be customized to support patient progression, resulting in many ways the REAL System can support clinicians and their patients. The REAL y-Series will be featured at Penumbra’s booth (#320) during this week’s American Occupational Therapy Association Annual Conference & Expo.

“Our next generation REAL y-Series represents our next step in fulfilling our vision for a healthcare-specific platform. Our innovations address the continued needs of clinicians while considerably improving care and bringing forward the latest advancements in software, hardware and analytics to enrich traditional physical and occupational therapies,” said Gita Barry, executive vice president and general manager of Penumbra’s Immersive Healthcare business. “Our aim is to continue to develop and partner with others to create a comprehensive library of activities across one platform so clinicians can easily access customizable tools with clinically experienced support teams to help a broad range of patients.”

The REAL System platform is designed to address a wide range of health conditions for more than 50 million patients and their providers. The platform includes the company’s proprietary hardware, provider-focused platform and system software, patient-engaging activities and experiences, and secure, compliant data and analytics. REAL y-Series is the latest generation of the REAL Immersive System that has supported more than 3,000 patients in the U.S. The REAL System platform also includes the REAL i-Series, a gaze-based virtual-reality system designed to address the cognition and mental well-being of users in a wide-variety of healthcare settings, including inpatient and outpatient facilities, senior living and employee wellness.

About the REAL Immersive System Portfolio

Penumbra’s REAL Immersive System is a platform of products that leverages virtual reality to deliver engaging, immersive healthcare designed to promote better health, including furthering functional skills, cognition and stress management. Built on advanced technology with a growing library of VR-based activities and experiences, the REAL Immersive System platform is comprised of two product solutions: REAL y-Series for clinical rehabilitation and REAL i-Series for wellness.

SourcePenumbra

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version